Work

Abstract CT177: Epacadostat plus durvalumab in patients with advanced solid tumors: preliminary results of the ongoing, open-label, phase I/II ECHO-203 study

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2018-ct177

Authors: Aung Naing, John D. Powderly, Gerald Falchook, Benjamin Creelan, John Nemunaitis, Jose Lutzky, Adi Diab, Judy S. Wang, Naomi Laing, Michelle Niewood, Xiaohua Gong, Gongfu Zhou, Manish Patel

Institutions: The University of Texas MD Anderson Cancer Center, Carolina BioOncology Institute, HealthONE, Moffitt Cancer Center, Mary Crowley Cancer Research Center, University of Toledo, Mount Sinai Medical Center, AstraZeneca (United States), Genmab (United States), Incyte (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2885415670

Cites:

Cited by: 26

Related to: 10